Oxidative Stress Assay Market Share, Growth Report, 2024-2032
Oxidative Stress Assay Market Share, Growth Report, 2024-2032

Oxidative Stress Assay Market Share, Size, Trends, Industry Analysis Report, By Product (Consumables, Kits, Reagents, Instruments, Services); By Test Type; By Technology; By Disease Type; By End User; By Region; Segment Forecast, 2024 - 2032

  • Published Date:Jun-2024
  • Pages: 115
  • Format: PDF
  • Report ID: PM4928
  • Base Year: 2023
  • Historical Data: 2019-2022

Report Outlook

Oxidative Stress Assay Market size was valued at USD 0.99 billion in 2023. The market is anticipated to grow from USD 1.06 billion in 2024 to USD 2.12 billion by 2032, exhibiting the CAGR of 9.1% during the forecast period.

Market Overview

The increasing number of people suffering from multiple diseases is showcasing the need for the development and formulation of effective drug therapies and medications at the global level. To assess the health condition of an individual, an oxidative stress assay is a key performance indicator widely utilized, driven by its potential to evaluate the antioxidant levels, free radicals, and their balance in the human body. The growing investments in research activities are optimally facilitating the new growth opportunities for the global oxidative stress assay market.

  • For instance, in December 2023, a researcher from the U.S. Department of Defense received a USD 313,000 grant from the Department of Physical Therapy and Kinesiology to understand the mechanism and develop treatment for the pathological development of Friedreich’s ataxia in muscles. In people with atoxia, the accumulation of iron leads to oxidative stress, causing mitochondrial dysfunction.

Oxidative Stress Assay Market Size

To Understand More About this Research:Request a Free Sample Report

Growth Drivers

Rising penetration of cancer

The rising incidence of cancer initiated the need for developing efficient diagnosis process by research organizations. As per the International Agency for Research on Cancer Estimates 2023, around 35 Mn new cancer cases are expected to reach, by 2050, from 20 Mn, in 2022. Free radicals cause huge damage to lipids, proteins, & DNA, leading to many unlikely lifestyle diseases.

For instance, a 2024 study explored the effects of oxidative stress, signaling pathways, and the cell communication system in cancer and showed the potential treatment possibilities, such as anti-oxidant-based, redox-modulating agents, and others that recover the signaling pathways and normal cell function impacted by oxidative stress.

An increase in research activities in the pharmaceutical space

The growing research initiatives by scientists and researchers to understand the disease mechanism and treatment procedures. Oxidative stress assays are gaining utility in cosmetic formulations, clinical laboratories, academic research institutes, and more in the marketplace. For instance, a 2023 study published in Springer Link focused on exploring the impact of oxidative stress, toxicity, anti-oxidants, and reactive oxygen species on ageing and chronic diseases. As more studies evaluate the potential effects of oxidative stress and diseases, there will be a significant demand for oxidative stress assays in the foreseeable future.

Restraining Factors

The huge cost of oxidative stress assays is likely to impede market growth

The increased cost of oxidative stress assays in the marketplace is expected to reduce the demand for these kits around the world. The presence of substitutes for oxidative stress, mainly, imaging technologies, is anticipated to limit the expansion of the oxidative stress assay market worldwide.

Report Segmentation

The market is primarily segmented based on product, test type, technology, disease type, end user, and region.

By Product

By Test Type

By Technology

By Disease Type

By End-User

By Region

  • Consumables
  • Kits
  • Reagents
  • Instruments
  • Services


  • Antioxidant Capacity Assays
  • Ascorbic Acid Assays
  • Glutathione Assays
  • Cell-based Exogenous Antioxidant Assays
  • Indirect Assays
  • Lipid-based Assays
  • Nucleic Acid-based Assays
  • Protein-based Assays
  • Enzyme-based Assays
  • Reactive Oxygen Species-based Assays


  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Flow Cytometry
  • High-content Screening (HCS)
  • Label-free Detection
  • Microscopy
  • Chromatography



  • Cardiovascular Disease
  • Diabetes
  • Cancer
  • Respiratory Diseases
  • Other Diseases
  • Clinical Laboratories
  • Contract Research Organizations
  • Pharmaceutical and Biotechnology Companies
  • Academic Research Institutes
  • Cosmetic Companies
  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

To Understand the Scope of this Report:Speak to Analyst

By Product Analysis

Consumables segment is expected to witness the highest growth during the forecast period

The consumables segment will grow rapidly, mainly driven by its affordability. There is a growing need for single-use laboratory tools, as certain experiments and research activities require different types of equipment. It is widely employed in laboratory settings due to its convenience and ease of application. The availability of effective oxidative stress assay consumables and the growing innovation of developing convenient assays are stimulating the use of consumables rather than kits as they enable researchers to utilize upgraded products.

The kits segment led the global market with a substantial revenue share in 2023, largely attributable to making users purchase the kit once and use it multiple times in the research phases. Oxidative stress assay kits are made by combining the required tools for testing oxidative stress in one place, leading to enhanced convenience among the users.

By Disease Type Analysis

Cardiovascular disease segment is expected to register significant growth

The cardiovascular disease segment is anticipated to witness significant growth during the assessment period, driven by the growing prevalence of cardiovascular diseases, contributing to the research activities on diagnosis and treatment procedures. According to the study published in the Journal of the American College of Cardiology in 2022, the prevalence of cardiovascular disease risk factors is estimated to grow from 2025 to 2060 due to rising diabetic cases by 39.3% (55 million), dyslipidemia, and hypertension.

By End-User Analysis

Pharmaceutical and Biotechnology companies is projected to facilitate significant demand

The pharmaceutical & biotechnology companies’ segment is anticipated to register significant demand in the study timeframe, primarily attributable to the increasing number of companies engaging in research and development activities to promote drug discovery and treatment planning. The ongoing expansion of the cosmetic industry and the increasing prevalence of chronic diseases are further bolstering the research studies, significantly driving the demand for oxidative stress assays in the global market.

Regional Insights

North America region registered the largest share of the global market in 2023

The North America region held the dominant growth share. This is due to the presence of established healthcare providers and market players in the region, specifically the United States and Canada. Growing government support for conducting research studies on chronic health issues such as cancer and diabetes is driving the demand for oxidative stress assays in the marketplace. According to the 2023 study published in The Lancet Oncology, the United States invested 57.3% of total cancer funding of USD 14 billion from 2016-2020 in cancer research, followed by the UK, Europe, and Japan.

The Asia Pacific region is expected to be the fastest growing region with a healthy CAGR during the projected period, owing to the growing investments in healthcare infrastructure development by the major countries, such as India and China. According to the Indian Express, a news agency, Param Hansa Centre sponsored the development of a cancer research Centre, Param Hansa Centre for Computational Oncology (PHCCO), at the Indian Institute of Science (IISc), Bengaluru, which is launched in November 2023 with an investment of USD 1 million in the next seven years. The growing pharmaceutical research experiments in the region are expected to create significant opportunities for oxidative stress assays in the region.

Key Market Players & Competitive Insights

Strategic partnerships to drive the competition

The oxidative stress assay market is fragmented. The growing initiatives taken by market players to enhance their production capacity to meet increasing demand in the global market are further boosting market expansion. In addition, new oxidative stress assays by the companies are anticipated to drive competition. For instance, in February 2024, Arbor Assay introduced its new assay, DetectX Thromboxane B2 (TXB2) ELISA Kit (K092-H), to its DetectX kit product line for cardiovascular research.

Some of the major players operating in the global market include:

  • Abcam, plc (UK)
  • AMS Biotechnology (Europe), Ltd. (UK)
  • Arbor Assays (US)
  • Callegari SRL (Italy)
  • Cayman Chemical (US)
  • Cell Biolabs, Inc. (US)
  • Eagle Biosciences, Inc. (US)
  • Enzo Biochem, Inc. (US)
  • Genox Corporation (US)
  • Hycult Biotech (Netherlands)
  • ImmunoChemistry Technologies, LLC (US)
  • Kamiya Biomedical Company (US)
  • MEGA TIP San. Tic.Ltd.Sti. (Turkey)
  • Merck KGaA (Germany)

Recent Developments in the Industry

  • In August 2023, Danaher Corporation, signed a definitive agreement to acquire Abcam plc, a provider of protein consumables, and assays to speed up the drug discovery procedures.

Report Coverage

The oxidative stress assay market report emphasizes on key regions across the globe to provide better understanding of the product to the users. Also, the report provides market insights into recent developments, trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the report covers in-depth qualitative analysis pertaining to various paradigm shifts associated with the transformation of these solutions.

The report provides detailed analysis of the market while focusing on various key aspects such as competitive analysis, product, test type, technology, disease type, end user, and their futuristic growth opportunities.

Oxidative Stress Assay Market Report Scope

Report Attributes


Market size value in 2024

USD 1.06 billion

Revenue forecast in 2032

USD 2.12 billion


9.1% from 2024 – 2032

Base year


Historical data

2019 – 2022

Forecast period

2024 – 2032

Quantitative units

Revenue in USD billion and CAGR from 2024 to 2032

Segments covered

  • By Product
  • By Test Type
  • By Technology
  • By Disease Type
  • By End-User
  • By Region

Regional scope

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Competitive Landscape

  • Oxidative Stress Assay Market Share Analysis (2023)
  • Company Profiles/Industry participants profiling includes company overview, financial information, product/service benchmarking, and recent developments

Report Format

  • PDF + Excel


Report customization as per your requirements with respect to countries, region and segmentation.


Oxidative Stress Assay Market Size Worth $ 2.12 Billion By 2032.

The top market players in the Oxidative Stress Assay Market are Abcam, AMS Biotechnology, Arbor Assays, BioVision

North America is the region contribute notably towards the global Oxidative Stress Assay Market.

Oxidative Stress Assay Market exhibiting the CAGR of 9.1% during the forecast period

The Oxidative Stress Assay Market report covering key segments are product, test type, technology, disease type, end user, and region.